158 views4 min read
Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker Symbol βDRUGβ
VANCOUVER, British Columbia, Nov. 03, 2021 -- Bright Minds Biosciences (βBright Minds,β βBMBβ or the βCompanyβ) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain, today announced that The Nasdaq Stock Market LLC has approved the lis... Read More...